| Financial Year |
March 31 2023 |
| Monetary Funds |
1,020,861,727.50 |
| Held-for-trading Financial Assets |
24,526,890.45 |
| Notes Receivable |
57,804,706.40 |
| Accounts Receivable |
3,981,775,614.31 |
| Advances to Suppliers |
872,211,179.19 |
| Other Receivables |
556,760,967.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,713,329,940.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
88,646,416.81 |
| Other Current Assets |
246,350,578.86 |
| Total Current Assets |
10,221,503,997.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
654,593,231.59 |
| Long-term Equity Investment |
745,043,920.44 |
| Investment Properties |
62,229,615.31 |
| Fixed Assetes |
4,341,384,356.83 |
| Under-construction Projects |
1,462,613,414.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,650,187,140.87 |
| R&D expenses |
54,116,777.14 |
| Goodwill |
678,998,856.87 |
| Long-Term Deferred and Prepaid Expenses |
58,571,293.75 |
| Deferred Income Tax Assets |
229,399,576.11 |
| Other Non-Current Assets |
388,052,939.56 |
| Sub-Total of Non-Current Assets |
13,539,270,078.25 |
| Total Assets |
23,760,774,076.02 |
| Short-Term Loans |
2,961,962,852.48 |
| Trading Financial liabilities |
19,094.14 |
| Notes Payable |
98,108,508.97 |
| Accounts Payable |
2,212,918,550.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
206,834,593.48 |
| Taxes Payable |
191,079,129.90 |
| Interest Payable |
-- |
| Dividend Payable |
95,025,559.28 |
| Other payables |
579,708,700.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,056,652,492.97 |
| Other Current Liabilities |
102,322,545.58 |
| Sub-Total of Current Liabilities |
8,338,946,925.79 |
| Long-term Loans |
6,701,255,742.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
153,320,061.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
109,936,109.61 |
| Deferred Income Tax Liabilities |
55,072,479.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,724,399,446.59 |
| Total Liabilities |
16,063,346,372.38 |
| Paid-In Capital(Or Share Stock) |
1,434,486,079.00 |
| Capital Surplus |
1,483,031,996.32 |
| Surplus Reserve |
402,341,533.69 |
| LESS:Treasury Stock |
101,536,350.00 |
| Undistributed Profits |
3,346,538,294.27 |
| Minority Stockholder's Interest |
1,165,221,137.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,532,206,566.06 |
| Owner's Equity（Stockholder's Equity） |
7,697,427,703.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,760,774,076.02 |
